AI, AMD and Absci

AMD invests $20M in AI-powered drug discovery company Absci
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop new hardware and software optimized for the healthcare sector. The effort will place particular emphasis on developing technologies that can advance drug discovery.
AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips
The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices Inc (NASDAQ:AMD) to enhance its AI drug discovery capabilities.
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power critical AI drug discovery workloads,
AMD invests $20 million in AI drug research at Vancouver-based Absci
Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial intelligence to develop new drug therapies. Absci hopes artificial intelligence will enable it to move faster to develop protein-based medicines called biologics,
Advanced Micro Devices, Inc. (AMD) Partners with Dell to Power New Pro Devices with Ryzen AI PRO Processors for Enhanced Business Productivity
We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...
Why Advanced Micro Devices Stock Was Double-Downgraded
HSBC lowered its rating on Advanced Micro Devices stock amid several concerns including the chipmaker's ability to compete ...
Only Room For The Best Or Cheapest, And AMD Is Neither: Downgrading To Sell
Advanced Micro Devices lags Nvidia in AI design wins, prompting a downgrade to sell. See why AMD stock faces little room to ...
Got $3,000? 2 Artificial Intelligence (AI) Stocks to Buy and Hold for the Long Term
Artificial intelligence (AI) has come a long way in recent years. Businesses are starting to see tangible savings from ...
AMD debuts AI-optimized laptop processor that can run large language models
In an internal test, AMD used the Ryzen AI Max+ 395 to run a version of the Llama 70B large language model. The company says ...
AMD: A Strong Buy As AI Datacenter Ramps Up In 2025
Advanced Micro Devices' diversified revenue streams provide a cushion against potential slowdowns in AI hardware CapEx. See ...
Is Advanced Micro Devices (AMD) Stock a Buy Now?
It's clear that AMD isn't the AI company Nvidia is. Its $3.5 billion in data center revenue in Q3 was a fraction of Nvidia's ...
Analyst: Advanced Micro Devices (AMD)’s Pipeline Lacks Nvidia’s By More Than a Year
We recently published a list of 10 AI Stocks Wall Street is Talking About. In this article, we are going to take a look at ...
Absci Shares Rise 27% on Report of $20 Mln Investment from Advanced Micro Devices
Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. The stock was up 27% to $3.89 in pre-market trading. Through Tuesday's close, shares ...